2010 annual financial data
Alnylam Pharmaceuticals 2010 Operating margin
Direct answer
Operating margin was -44.05%.
Operating income was -44,070,000 USD and net income was -43,515,000 USD.
Operating cash flow was -84,341,000 USD.
Get free Alnylam Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 100,041,000 USD
- Operating income
- -44,070,000 USD
- Net income
- -43,515,000 USD
- Operating cash flow
- -84,341,000 USD